Skip to Content

250 mg 893 (Temozolomide 250 mg)

Pill with imprint 250 mg 893 is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Sun Pharma Global FZE.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 250 mg 893

Temozolomide

Imprint
250 mg 893
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharma Global FZE
National Drug Code (NDC)
47335-0893

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.